An Inhibitor of Macrophage Accumulation Produced by Neoplasms: Its Role in Abrogating Host Resistance to Cancer
- 1 January 1980
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.The Journal of Experimental Medicine, 1978
- Abnormal Monocyte Chemotaxis in Patients With Breast Cancer: Evidence for a Tumor-Mediated Effect2JNCI Journal of the National Cancer Institute, 1978
- Generation of macrophage chemotactic activity in situ in Listeria-immune ratsCellular Immunology, 1977
- Abnormalities of Monocyte Chemotaxis in Patients With Melanoma: Effects of Immunotherapy and Tumor Removal2JNCI Journal of the National Cancer Institute, 1977
- An Inhibitor of Macrophage Chemotaxis Produced by NeoplasmsScience, 1976
- Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.The Journal of Experimental Medicine, 1976
- Antiinflammatory Effects of Murine Malignant CellsProceedings of the National Academy of Sciences, 1974
- QUANTITATIVE STUDY ON THE PRODUCTION AND KINETICS OF MONONUCLEAR PHAGOCYTES DURING AN ACUTE INFLAMMATORY REACTIONThe Journal of Experimental Medicine, 1973
- Mechanism of Immunologically Specific Killing of Tumour Cells by MacrophagesNature, 1972
- THE ORIGIN AND TURNOVER OF MONONUCLEAR CELLS IN PERITONEAL EXUDATES IN RATSThe Journal of Experimental Medicine, 1966